SADIKO

This brand name is authorized in Nigeria.

Active ingredients

The drug SADIKO contains one active pharmaceutical ingredient (API):

1	Diclofenac UNII QTG126297Q - DICLOFENAC SODIUM
	Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.
	Read more about Diclofenac

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-5568	Tablet	SADIKO TABLETS TAB 100 mg 1X10TABLETS	SADIKO TABLETS DICLOFENAC SODIUM 100MG DICLOFENAC SODIUM 100MG ,EXCIPIENTS Q.S B4-5568 Drugs Imported Products 1X10TABLETS Prescription Only Medicine (POM) 30/09/2020 SAM SUNNY PHARMACY AND STORES LIMITED, NO.1, ISAACGIDEONCLOSE, AJANGBADI, 7037831095 ezesunday166@gmail.com JIANGXI XIER KANGTAI PHARM CO LTD., NORTH ZONE, HIGH, NEW TECHNOLOGY INDUSTRIAL ZONE, PINGIXIANG, CHINA, China	31/08/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AB05	Diclofenac	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-5568